Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J van den Bemd

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1990
Peritoneal macrophages from patients on CAPD show an increased capacity to secrete interleukin-1 beta during peritonitisM W Fieren, G J van den Bemd, I L Bonta
Prostaglandins, Leukotrienes, and Essential Fatty Acids|September 1, 1992
Peritoneal macrophages from patients on continuous ambulatory peritoneal dialysis show a differential secretion of prostanoids and interleukin-1 betaM W Fieren, G J van den Bemd, I L Bonta
European Journal of Clinical Investigation|August 1, 1990
Endotoxin-stimulated peritoneal macrophages obtained from continuous ambulatory peritoneal dialysis patients show an increased capacity to release interleukin-1 beta in vitro during infectious peritonitisM W Fieren, G J Van den Bemd, I L Bonta
Current Pharmaceutical Design|June 1, 2000
Anti-tumor effects of 1,25-dihydroxyvitamin D3 and vitamin D analogsG J van den Bemd, H A Pols, J P van Leeuwen
Immunology Letters|January 1, 1992
Prostaglandin E2 inhibits the release of tumor necrosis factor-alpha, rather than interleukin 1 beta, from human macrophagesM W Fieren, G J van den Bemd, S Ben-Efraim, et al.
Journal of Clinical & Laboratory Immunology|January 1, 1991
Peritoneal macrophages from patients on continuous ambulatory peritoneal dialysis have an increased capability to release tumour necrosis factor during peritonitisM W Fieren, G J van den Bemd, I L Bonta, et al.
Biochemical and Biophysical Research Communications|July 16, 1999
Distinct effects on the conformation of estrogen receptor alpha and beta by both the antiestrogens ICI 164,384 and ICI 182,780 leading to opposite effects on receptor stabilityG J Van Den Bemd, G G Kuiper, H A Pols, et al.
Critical Reviews in Eukaryotic Gene Expression|November 6, 2001
Vitamin D control of osteoblast function and bone extracellular matrix mineralizationJ P van Leeuwen, M van Driel, G J van den Bemd, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1991
Inflammation amplifies the antitumor cytostasis by human peritoneal macrophagesS Ben-Efraim, C Tak, M J Fieren, et al.
Bone|March 1, 1997
Consequences of vitamin D receptor regulation for the 1,25-dihydroxyvitamin D3-induced 24-hydroxylase activity in osteoblast-like cells: initiation of the C24-oxidation pathwayA Staal, G J van den Bemd, J C Birkenhäger, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1990
Peritoneal macrophages from patients on CAPD show an increased capacity to secrete interleukin-1 beta during peritonitisM W Fieren, G J van den Bemd, I L Bonta
Prostaglandins, Leukotrienes, and Essential Fatty Acids|September 1, 1992
Peritoneal macrophages from patients on continuous ambulatory peritoneal dialysis show a differential secretion of prostanoids and interleukin-1 betaM W Fieren, G J van den Bemd, I L Bonta
European Journal of Clinical Investigation|August 1, 1990
Endotoxin-stimulated peritoneal macrophages obtained from continuous ambulatory peritoneal dialysis patients show an increased capacity to release interleukin-1 beta in vitro during infectious peritonitisM W Fieren, G J Van den Bemd, I L Bonta
Current Pharmaceutical Design|June 1, 2000
Anti-tumor effects of 1,25-dihydroxyvitamin D3 and vitamin D analogsG J van den Bemd, H A Pols, J P van Leeuwen
Immunology Letters|January 1, 1992
Prostaglandin E2 inhibits the release of tumor necrosis factor-alpha, rather than interleukin 1 beta, from human macrophagesM W Fieren, G J van den Bemd, S Ben-Efraim, et al.
Journal of Clinical & Laboratory Immunology|January 1, 1991
Peritoneal macrophages from patients on continuous ambulatory peritoneal dialysis have an increased capability to release tumour necrosis factor during peritonitisM W Fieren, G J van den Bemd, I L Bonta, et al.
Biochemical and Biophysical Research Communications|July 16, 1999
Distinct effects on the conformation of estrogen receptor alpha and beta by both the antiestrogens ICI 164,384 and ICI 182,780 leading to opposite effects on receptor stabilityG J Van Den Bemd, G G Kuiper, H A Pols, et al.
Critical Reviews in Eukaryotic Gene Expression|November 6, 2001
Vitamin D control of osteoblast function and bone extracellular matrix mineralizationJ P van Leeuwen, M van Driel, G J van den Bemd, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1991
Inflammation amplifies the antitumor cytostasis by human peritoneal macrophagesS Ben-Efraim, C Tak, M J Fieren, et al.
Bone|March 1, 1997
Consequences of vitamin D receptor regulation for the 1,25-dihydroxyvitamin D3-induced 24-hydroxylase activity in osteoblast-like cells: initiation of the C24-oxidation pathwayA Staal, G J van den Bemd, J C Birkenhäger, et al.
Pageof 2